Navigation Links
Bluemetal Architects appoints David Le Penske as Vice President of Health & Life Sciences
Date:1/30/2013

WATERTOWN, Mass., Jan. 30, 2013 /PRNewswire-iReach/ -- BlueMetal Architects, a leading design and technology services firm, today announced that it has appointed former Microsoft Health Solutions Group Director and Health IT entrepreneur, David Le Penske , to be Vice President of Health & Life Sciences.  Mr. Le Penske will be based in BlueMetal's Boston office and will be responsible for leading the Health and Life Sciences growth strategy for the company across BlueMetal's Boston, New York and Chicago locations.

Mr. Le Penske has a long track record of entrepreneurial and corporate leadership experience across sales, marketing, and development of strategic partnership alliances, including the last 10 years specifically in the Health IT industry. Most recently, he served as Vice President of Business Development and Sales for Get Real Health, a leading Maryland-based consumer health software company.  Prior to that, Mr. Le Penske served as Director, Microsoft Health Solutions Group where he was responsible for leading Microsoft's enterprise Amalga and consumer HealthVault sales and business development initiatives across Canada's government, business and consumer markets – including the MyHealth Alberta citizen portal project. Mr. Le Penske also managed the strategic partner relationship with TELUS concerning TELUS health space, powered by Microsoft HealthVault.

In 2003, Mr. Le Penske founded AccelMD, a leading supplier of healthcare information and navigation services and wellness solutions, to improve health and enhance the quality of life for individuals, groups and organizations.  As co-founder and CEO, he led AccelMD's business growth strategy and was responsible for driving revenue and expanding service solution offerings including a distribution agreement with Manulife Financial Corporation's Group and Individual Benefits divisions. He and his partners sold the company to WorldCare of Boston, MA in 2012.

"In my view, there has simply never been a greater time in the history of medicine where technology can make such a profoundly positive impact," said Mr. Le Penske .  "Similar to financial services a decade ago, healthcare data and insights should be securely and readily accessible to approved users on any device that connects to the internet, and modern applications will play a pivotal role in making our health easy to understand, self-serve and more accountably managed."

"David has a tremendous vision for the future of Health Care, where heterogeneous data can be combined into a highly secure cloud-based "big data" asset that can be connected to modernized workflows and applications to facilitate collaboration across the continuum of care," said Todd Bremner , CEO and Chief Architect of BlueMetal Architects. "BlueMetal's design and delivery capabilities will speed the impact of David's vision to enable research-based medicine to become a more connected and personalized evidence-based care."

In the coming year Mr. Le Penske will work with BlueMetal's practice teams and General Managers in Boston, New York, and Chicago to drive strategy and execution focused on winning key projects to advance the state of the art in Health and Life Sciences by increasing client, strategic partner and project revenue growth and market share across the Health and Life Sciences vertical.



Media Contact: Sadalit Van Buren BlueMetal Architects, (617) 431-5752, svanburen@bluemetal.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE BlueMetal Architects
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. 3-V Biosciences Appoints Douglas I. Buckley, PhD, as Vice President of Biology
2. Conatus Pharmaceuticals Appoints Mark F. Morris as Head of Biostatistics
3. AnaptysBio Adds Dr. David L. Lacey and Dr. Michael Gallatin to Therapeutic Advisory Board
4. The American Society for Microbiology honors David Tobin
5. Environmental activist David Suzuki is fifth recipient of CWRU’s Inamori Ethics Prize
6. President, CEO Leppävuori, VTT: Finland should create a national bioeconomy strategy
7. UCLAs Yi Tang receives Presidential Green Chemistry Challenge Award from EPA
8. NASA Goddard scientist receives Presidential Early Career Award
9. ONR-funded young innovators recognized by President
10. President Obama honors MU researcher with National Medal of Science
11. Tortoise and the hare: New drug stops rushing cancer cells, slow and steady healthy cells unharmed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2016)... Nov. 21, 2016   Neurotechnology , a ... technologies, today announced that the MegaMatcher On Card ... submitted for the NIST Minutiae Interoperability Exchange ... the mandatory steps of the evaluation protocol. ... continuing test of fingerprint templates used to establish ...
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, Inc. ... therapeutics focused on the gut microbiome, today announced ... 25,000,000 shares of its common stock and warrants ... at a price to the public of $1.00 ... Synthetic Biologics from the offering, excluding the proceeds, ...
(Date:6/22/2016)...  The American College of Medical Genetics and Genomics was ... as one of the fastest-growing trade shows during the Fastest ... in Las Vegas . ... in each of the following categories: net square feet of ... attendees. The 2015 ACMG Annual Meeting was ranked 23 out ...
Breaking Biology News(10 mins):
(Date:11/30/2016)... 30, 2016 The global Pyrogen ... hold a dominant share in the overall market. The ... Inc., and Merck KGaA, held a lion,s share of ... Research observes that these companies are expected to retain ... that are do not require rabbit pyrogen testing along ...
(Date:11/30/2016)... 2016  Tempus, a technology company focused on ... Abramson Cancer Center have partnered to better determine ... immunotherapy treatment based on next generation genomic and ... a research collaboration, Tempus will provide sequencing and ... data to Penn. Utilizing next-generation sequencing, machine learning ...
(Date:11/30/2016)... ... November 30, 2016 , ... SSCI, the established leader in small-molecule ... of the latest FDA guidance on pharmaceutical cocrystals as drug substance . ... , The event follows the successful November 15th event that took place ...
(Date:11/30/2016)... Toronto, ON (PRWEB) , ... November 30, 2016 ... ... focused on discovery and development of precision treatments for neurodegenerative diseases, today announced ... disease (AD) (announced on November 3, 2016) blocked propagation of toxic, prion-like forms ...
Breaking Biology Technology: